Mandate

Vinge has advised Amasten Fastighets AB in connection with a directed share issue

September 15, 2020 Capital Markets and Public M&A

Vinge has advised Amasten Fastighets AB (“Amasten”), a real estate company, in connection with a directed share issue whereby Amasten receives SEK 500 million in issue proceeds.

The subscription price was determined to SEK 7.30 per share through an accelerated book building process. The share issue was directed to selected Swedish and international investors. The main purpose of the share issue is to finance continued growth through acquisitions of investment properties and development projects.

Vinge’s team consisted of Jesper Schönbeck, Rikard Lindahl, Malte St Cyr Ohm and Amanda M Johansson.

 

Related

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025